Latest CSL News

Preparing Australians for COVID-19 vaccination roll-out
Appointments to Reserve Bank of Australia Board
Australia secures 20 million extra Astra Zeneca vaccines for onshore manufacturing
Australia secures 20 million extra Astra Zeneca vaccines
AFAO statement on UQ vaccine candidate
Update on University of Queensland COVID-19 vaccine
Update on UQ COVID-19 vaccine
Australian researcher recognised for work in developing next generation treatments for Parkinson’s disease
Survey of ASX leaders shows how businesses can rise in 2021
COVID-19 vaccine alternative protein and unlocking Northern Australia celebrated at CSIRO awards
National recognition for WEHI bioinformatics researchers
Expert commentary: Oxford and AstraZeneca vaccine preliminary Phase III data
Nanobodies could hold clues to new COVID-19 therapies
$1 billion manufacturing agreement secures Australia’s national health security
A new vaccine facility for Melbourne
Interview with Neil Mitchell, 3AW
World-Leading Vaccine Facility Secures Jobs For Victoria
Seqirus will build world-class, next-generation $800m influenza vaccine manufacturing facility in Australia
New Australian Institute for Infectious Disease for Parkville biomedical precinct
Australia to get new hub for infectious diseases and global health
Victorian Pledge For Institute Of Infectious Disease
University of Oxford/AstraZeneca Vaccine Candidate
CSL Commences Manufacturing of University of Oxford/AstraZeneca Vaccine Candidate in Melbourne
Novel anti-inflammatory therapy improves heart recovery after a heart attack
Australian seafarers outraged after Federal Government grants foreign workers COVID exemptions to take coastal
Australia may miss out on several COVID vaccines if it cannot make mRNA ones locally
Australia Secures a further 50 Million Doses of COVID-19 Vaccine
Baker Institute-led group develops proposed nationwide protocol for storing carbon
CSL Named as One of World’s Best Employers
Australian research at centre of landmark treatment trial for COVID-19
CSL’s Annual Research and Development Day Briefing
‘Multi-omics’ adds new cell to immune family tree
2021 CSL Centenary Fellowships Announced
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine
Australian Government finalises University of Queensland-CSL COVID-19 vaccine agreement
Budget 2020-21: Record health and aged care investment under Australia’s COVID-19 pandemic plan
Joy Linton named as Chief Financial Officer
CSL signs agreement with Australian Government for UQ vaccine supply
Onshore manufacturing agreement for COVID-19 vaccines
CSL to manufacture and supply University of Queensland and Oxford University vaccine candidates for Australia
Appointment of Non-executive Director 4 September
World-first Aussie innovations among finalists for prestigious research commercialisation awards
Urgent call for older Queenslanders to volunteer for COVID-19 study
Volunteers needed for next phase of trials on Qld COVID-19 vaccine
Outstanding researchers receive science awards
National Cabinet 22 August
CSIRO welcomes vaccine agreement with AstraZeneca-Oxford University
New deal secures potential COVID-19 vaccine for every Australian